Originally published December 11 2003
Canadians file class action lawsuit against antidepressant drug maker
by Mike Adams, the Health Ranger, NaturalNews Editor
Serzone, one of several dangerous antidepressant drugs now available on the market, has killed dozens of patients and injured many more. In Canada, citizens are joining a class action lawsuit against the drug maker. In the U.S., the FDA still refuses to ban Serzone. As well described on ADrugRecall.com, "Public Citizen consumer group petitioned the FDA to ban Serzone in March 2003. When the FDA failed to adequately respond to the group's request, they renewed its' call for the FDA to ban the antidepressant in October 2003. While Canadian officials announced they would ban Serzone because of its risks, critics of the U.S. agency wondered why the FDA had not made similar actions.
When the World Health Organization and Health Canada compared different antidepressant drugs, Serzone was the only one displaying increased risks for serious liver injury. The influence rich and powerful drug companies have over federal regulation has been questioned over the years. Serzone's allowance to remain on the market is yet another example of controversial safety regulating."
REVIEW TYPE
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml